nimesulide has been researched along with lassbio 294 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alexandre-Moreira, MS; Barreiro, EJ; Bechara, EJ; Bertho, AL; Calixto, JB; De-Paula, FS; Duarte, CD; Dutra, F; Ferreira, J; Fraga, CA; Goulart, MO; Lacerda, DI; Martins, MV; Miranda, AL; Nunes, MP; Tributino, JL | 1 |
Barreiro, EJ; Castro, NG; CorrĂȘa, RS; Doriguetto, AC; Duarte, CD; Ellena, J; Fraga, CA; Miranda, AL; Romeiro, NC; Tributino, JL | 1 |
2 other study(ies) available for nimesulide and lassbio 294
Article | Year |
---|---|
Synthesis, pharmacological evaluation and electrochemical studies of novel 6-nitro-3,4-methylenedioxyphenyl-N-acylhydrazone derivatives: Discovery of LASSBio-881, a new ligand of cannabinoid receptors.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Antioxidants; Arachidonic Acid; Arachidonic Acids; Biphenyl Compounds; Brain; Cannabinoid Receptor Modulators; Carrageenan; Cell Proliferation; Edema; Endocannabinoids; Female; Formaldehyde; Free Radical Scavengers; Hydrazines; Hydrazones; Ligands; Male; Mice; Models, Molecular; Pain; Picrates; Polyunsaturated Alkamides; Pyridines; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Superoxides; T-Lymphocytes | 2007 |
Novel 6-methanesulfonamide-3,4-methylenedioxyphenyl-N-acylhydrazones: orally effective anti-inflammatory drug candidates.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzodioxoles; Carrageenan; Computer Simulation; Crystallography, X-Ray; Cyclooxygenase Inhibitors; Disease Models, Animal; Edema; Female; Hydrazones; Male; Rats; Rats, Wistar; Thermodynamics | 2009 |